Metronomic Temozolamide in Patients With Recurrent Glioblastoma

NCT01308632 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Temozolamide, irinotecan

Sponsor

Grupo Español de Investigación en Neurooncología